期刊文献+

河南省某三甲医院342例次造血干细胞移植术后感染病原菌分布和耐药性分析 被引量:1

Analysis of the distribution and drug resistance of pathogenic bacteria isolated from 342 cases of patients of infection after hematopoietic stem cell transplantation in a third grade A hospital in Henan province
原文传递
导出
摘要 目的分析造血干细胞移植术后感染特点、病原菌分布及耐药情况,为临床合理选用抗菌药物提供依据。方法回顾性分析2015年1月至2020年1月郑州大学第一附属医院342例次造血干细胞移植术后感染患者的临床资料,对感染类型、病原菌检出及耐药情况进行分析。结果342例次造血干细胞移植术后感染以血流感染为主(167例次,占48.8%),其次为肺部感染(18.4%)、皮肤软组织感染(9.4%)和胃肠道感染(8.2%)。共检出264株病原菌,其中革兰氏阴性杆菌187株(70.8%),革兰氏阳性菌59株(22.3%),真菌18株(6.9%)。革兰氏阴性杆菌以肺炎克雷伯菌(28.8%),铜绿假单胞菌(19.3%)和大肠埃希菌(11.0%)为主;革兰氏阳性菌以金黄色葡萄球菌(7.2%)和表皮葡萄球菌(6.1%)为主。肺炎克雷伯菌对亚胺培南和美罗培南耐药率分别为11.8%和13.2%,大肠埃希菌对亚胺培南和美罗培南耐药率分别为6.9%和10.3%,二者均对替加环素敏感。铜绿假单胞菌对亚胺培南和美罗培南耐药率分别为9.8%和7.8%。金黄色葡萄球菌和表皮葡萄球菌对苯唑西林耐药率分别为47.4%和87.5%,尚未发现对万古霉素、利奈唑胺耐药菌株。结论造血干细胞移植术后感染以血流感染最常见,病原菌以革兰氏阴性杆菌居多,应结合药敏结果合理选用抗菌药物,有效控制感染以提高移植成功率。 Objective To analyze the incidence of infection after hematopoietic stem cells transplantation in our hospital,so as to provide a basis for rational selection of antibacterial drugs in clinical practice.Methods The clinical data of a case of post-transplantation infection in the hematopoietic stem cell transplantation center of our hospital from January 2015 to January 2020were retrospectively analyzed,including the detection,distribution and drug resistance of strains.Results Bloodstream infection was the main infection after hematopoietic stem cell transplantation in 342 cases(48.8%),followed by pulmonary infection(18.4%),skin and soft tissue infection(9.4%)and gastrointestinal infection(8.2%).A total of 264 pathogenic bacteria were detected,including 187 strains of Gram-negative bacilli(70.8%),59 strains of gram-positive bacilli(22.3%)and 18 strains of fungi(6.9%).Gram-negative bacilli were mainly Klebsiella pneumoniae(28.8%),Pseudomonas aeruginosa(19.3%)and Escherichia coli(11.0%).The gram-positive bacteria were mainly Staphylococcus aureus(7.2%)and Staphylococcus epidermidis(6.1%).The drug resistance rates of Klebsiella pneumoniae to imipenem and meropenem were 11.9%and 14.3%respectively,and those of Escherichia coli to imipenem and Meropenem were 6.9%and 10.3%respectively,both of which were sensitive to tegacycline.The drug resistance rates of Pseudomonas aeruginosa to imipenem and Meropenem were 9.8%and 7.8%,respectively.The drug resistance rates of Staphylococcus aureus and Staphylococcus epidermidis were 47.4%and 87.5%,respectively.Strains resistant to vancomycin and linezolid have not been found.Conclusions Bloodstream infection is the most common infection after hematopoietic stem cell transplantation in our hospital.Gram-negative bacillus was the main pathogen.Antibacterial drugs should be reasonably selected in combination with drug sensitivity results,and infection should be effectively controlled to improve the success rate of transplantation.
作者 湛玉晓 樊文娟 杨阳 刘彩红 李福琴 ZHAN Yuxiao;FAN Wenjuan;YANG Yang;LIU Caihong;LI Fuqin(The First Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,China)
出处 《河南预防医学杂志》 2022年第5期359-361,388,共4页 Henan Journal of Preventive Medicine
关键词 造血干细胞移植 感染 细菌 耐药性 Hematopoietic stem cell transplantation Infection Bacteria Drug resistance
  • 相关文献

参考文献8

二级参考文献59

  • 1Clinical and Laboratory Standards Institute.Performance Stand-ards for Antimicrobial Susceptibility Testing[S].M100-S21.CLSI,2011.
  • 2Rina K,Nadeem SR,Kee PN.Etiology of blood culture iso-lates among patients in a multidisciplinary teaching hospital in Kuala Lumpur.Etiology of blood culture isolates in a teaching hospital[J].J Microbiol Immunol Infect,2007,40:432-437.
  • 3Hall KK,Lyman JA.Updated review of blood culture con-tamination[J].Clin Microbiol Rev,2006,19(4):788-802.
  • 4Long KS,Munck C,Andersen TM,et al.Mutations in23S rRNA at the peptidyl transferase center and their relationship to linezolid binding and cross-resistance[J].Antimicrob A-gents Chemother,2010,54(11):4705-4713.
  • 5Shen P,Wei ZQ,Jiang Y,et al.Novel Genetic Environment of the Carbapenem-Hydrolyzingβ-Lactamase KPC-2among Enterobacteriaceaein China[J].Antimicrob Agents Chemoth-er,2009,54(10):4333-4338.
  • 6Qi Y,Wei ZQ,Ji SJ,et al.ST11,the dominant clone of KPC-producing Klebsiella pneumoniae in China[J].J Antimi-crob Chemother,2011,66(2):307-312.
  • 7Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement. CLSI document M100-S25 [ S ] . Wayne, Pennsylvania:CLSI, 2015.
  • 8Leclercq R, Canton R, Brown DF, et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect,2013,19 ( 2 ) : 141-160.
  • 9中国合格评定国家认可委员会.医学实验室质量和能力认可准则在临床微生物学检验领域的应用说明.CNAS—CL42:2012.
  • 10Clinical and laboratory Standards Institute. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or fastidious Bacteria; Third Edition- Guideline Md5-A3, 2014.

共引文献6261

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部